Khaled Sanber
Department of Thoracic-Head & Neck Med Onc, Division of Cancer Medicine
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
2014 | University College London, London, GBR, PHD, Research |
2010 | University of Jordan, Amman, JOR, MD, Medical Doctor |
Postgraduate Training
2020-2023 | Clinical Fellowship, Medical Oncology, Johns Hopkins Hospital, Baltimore, MD |
2015-2020 | Clinical Residency, Internal Medicine, Cell and Gene Therapy, Baylor College of Medicine, Houston, TX |
2010-2011 | Clinical Internship, Al-Hussein Hospital, Al-Salt |
Board Certifications
2019 | American Board of Internal Medicine |
Selected Publications
Peer-Reviewed Articles
- Sanber K, Ly A, Ondo A, Mooney K, Baker J, Shedeck A, Wagner-Johnston N, Jain T. Outpatient CD28-costimulated CAR T-cells for B-cell malignancies with CNS involvement. Am J Hematol 98(11):E301-E304, 2023. e-Pub 2023. PMID: 37539824.
- Sanber K, Rosner S, Forde PM, Marrone KA. Neoadjuvant Immunotherapy for Non-Small Cell Lung Cancer. BioDrugs 37(6):775-791, 2023. e-Pub 2023. PMID: 37603233.
- Ly A, Sanber K, Tsai HL, Ondo A, Mooney K, Shedeck A, Baker J, Imus PH, Wagner-Johnston N, Jain T. Outpatient CD19-directed CAR T-cell therapy is feasible in patients of all ages. Br J Haematol 203(4):688-692, 2023. e-Pub 2023. PMID: 37642134.
- Sanber K, Ye K, Tsai HL, Newman M, Webster JA, Gojo I, Ghiaur G, Prince GT, Gondek LP, Smith BD, Levis MJ, DeZern AE, Ambinder AJ, Dalton WB, Jain T. Venetoclax in combination with hypomethylating agent for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary disease. Leuk Lymphoma 64(4):846-855, 2023. e-Pub 2023. PMID: 36744656.
- Sanber K, Savani B, Jain T. Graft-versus-host disease risk after chimeric antigen receptor T-cell therapy: the diametric opposition of T cells. Br J Haematol 195(5):660-668, 2021. e-Pub 2021. PMID: 34036558.
- Youness RA, Gad AZ, Sanber K, Ahn YJ, Lee GJ, Khallaf E, Hafez HM, Motaal AA, Ahmed N, Gad MZ. Targeting hydrogen sulphide signaling in breast cancer. J Adv Res 27:177-190, 2021. e-Pub 2020. PMID: 33318876.
- Shah C, Sanber K, Jacobson R, Kaul B, Tuthill S, Hemmige V, Guy E, Greenberg S. I-PASS Illness Severity Identifies Patients at Risk for Overnight Clinical Deterioration. J Grad Med Educ 12(5):578-582, 2020. PMID: 33149827.
- Hegde M, Joseph SK, Pashankar F, DeRenzo C, Sanber K, Navai S, Byrd TT, Hicks J, Xu ML, Gerken C, Kalra M, Robertson C, Zhang H, Shree A, Mehta B, Dakhova O, Salsman VS, Grilley B, Gee A, Dotti G, Heslop HE, Brenner MK, Wels WS, Gottschalk S, Ahmed N. Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma. Nat Commun 11(1):3549, 2020. e-Pub 2020. PMID: 32669548.
- Tijani M, Munis AM, Perry C, Sanber K, Ferraresso M, Mukhopadhyay T, Themis M, Nisoli I, Mattiuzzo G, Collins MK, Takeuchi Y. Lentivector Producer Cell Lines with Stably Expressed Vesiculovirus Envelopes. Mol Ther Methods Clin Dev 10:303-312, 2018. e-Pub 2018. PMID: 30182034.
- Ali AI, Badran YR, Hassuneh MR, Sanber KS, Ismail SI. Effect of Interleukins on Antibody Production by Epstein-Barr Virus Transformed B Cells. Monoclon Antib Immunodiagn Immunother 34(3):162-8, 2015. PMID: 26090593.
- Sanber KS, Knight SB, Stephen SL, Bailey R, Escors D, Minshull J, Santilli G, Thrasher AJ, Collins MK, Takeuchi Y. Construction of stable packaging cell lines for clinical lentiviral vector production. Sci Rep 5:9021, 2015. e-Pub 2015. PMID: 25762005.
Patient Reviews
CV information above last modified September 10, 2024